Sulfasalazine USP For Compounding (API)

Sulfasalazine USP for Compounding (API) is used in the formulation of customized medications primarily for the treatment of inflammatory conditions such as ulcerative colitis and rheumatoid arthritis. It is a disease-modifying anti-rheumatic drug (DMARD) that works by reducing inflammation and suppressing the immune system's response. In the gastrointestinal tract, sulfasalazine is broken down into active components that help alleviate symptoms of inflammation and pain, promoting healing in the colon and joint health. Compounding allows for tailored dosing and alternative formulations to meet specific patient requirements.

Sulfasalazine USP for compounding is a medication used in the preparation of customized medications for individual patients. It is used in compounding pharmacies to make formulations of sulfasalazine that are not commercially available, either due to patient-specific needs or shortages of commercially available products. Sulfasalazine is primarily used in the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It may also be used to treat other conditions such as rheumatoid arthritis and various skin conditions.

Sulfasalazine USP active pharmaceutical ingredients (API) refer to the chemical substances that are responsible for the therapeutic activity of the medication known by the brand names Azulfidine or Sulfazine. Sulfasalazine is a combination of sulfapyridine and salicylate, and it is used to treat ulcerative colitis, rheumatoid arthritis, and other inflammatory conditions. The sulfapyridine component acts as an antibiotic, while the salicylate component has anti-inflammatory properties. Sulfasalazine USP APIs are highly regulated and must meet specific standards set by the USP for safety, purity, and potency in order to be used in pharmaceutical products.

CAS Number: 599-79-1
Property: Light Sensitive